biotech
Aromatase Inhibitors Improve Survival Of Advanced Breast Cancer Patients
Filed in archive Drugs, Vaccines and Therapeutics by ruth on September 22, 2006
Aromatase Inhibitors Improve Survival Of Advanced Breast Cancer Patients
According to a meta-analysis study published in the Journal of the National Cancer Institute, aromatase inhibitors --such as vorozole, letrozole, examestane, and anastrazole-- improve the survival of advanced breast cancer patients and may therefore be used as an initial therapy for these patients. The use of third-generation aromatase inhibitors and inactivators appear to be significantly better than standard hormone therapies like tamoxifen.

An accompanying JNCI editorial says,
"We believe that this study was well executed and that the results are acceptable. The statistical power of this meta-analysis is high because of the large amount of compiled data, and the results support what is already a strong bias in the clinical community."


[Photo: Invasive Lobular carcinoma, Credit: Breastcancer.org]

Permalink: Aromatase Inhibitors Improve Survival Of Advanced Breast Cancer Patients
Tags: cancer  breast+cancer  tamoxifen  aromatase+inhibitors  chemotherapy  biotech  cancer+patients 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/36971
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Aromatase Inhibitors Improve Survival Of Advanced Breast Cancer Patients:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 1 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!